Data from Pharmawand - Curated by EPG Health - Date added 27 February 2018


Ovarian cancer is the biggest gynaecological killer of UK women, with UK survival rates amongst the worst in Europe. March is Ovarian Cancer Awareness Month.

Ovarian cancer is the fourth most common form of cancer death in women, after breast, lung and bowel cancer.  However, the average GP will see only one case of ovarian cancer every five years.

11 women die in the UK every day from ovarian cancer. Awareness of ovarian cancer is low, both amount women and GPs. Three quarters of women are diagnosed once the cancer has already spread, making treatment more difficult. That is why awareness is so important, to drive forward improvements in detection, treatment and ultimately survival.

 “Enough is enough, this March Start Making Noise so we can make sure women have the best chances of survival.”

Ovarian cancer in numbers:
  • About 7,300 women are diagnosed each year in the UK
  • 4,100 women lose their lives each year – that’s 11 women every day
  • A woman in the UK has a one in 50 chance of being diagnosed with ovarian cancer in her lifetime.
  • When a woman is diagnosed at the earliest stage, her chance of surviving ovarian cancer for five years or more double from just 46 per cent to more than 90 per cent
  • Nearly half of GPs (44 per cent) mistakenly believe symptoms only present in the later stages of ovarian cancer
  • Just one in five UK women (20 per cent) can name bloating as one of the main symptoms of ovarian cancer
  • Almost half of women (45 per cent) must wait three months or more from first visiting their GP to getting a correct diagnosis
  • Over a quarter of women with ovarian cancer (26 per cent) are diagnosed through an emergency presentation such as Accident and Emergency
  • One third (31 per cent) of women mistakenly think the cervical screening programme would detect ovarian cancer


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

CDK 4/6 inhibitors in metastatic breast cancer

CDK 4/6 inhibitors in metastatic breast cancer

The CDK 4/6 Inhibitors in Metastatic Breast Cancer Learning Zone provides insights and information for metastatic breast cancer (mBC) and CDK 4/6 signalling. This includes the burden and pathophysiology of the disease, the role of CDK 4/6 in cell proliferation and an overview of the CDK 4/6 inhibitors that have been approved for the management of mBC.

Chronic Lymphocytic Leukaemia (CLL)

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

+ 1 more

Cushing's Syndrome

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

+ 2 more

Load more

Related Content